申请人:Bayer Aktiengesellschaft
公开号:US04622332A1
公开(公告)日:1986-11-11
Compounds of the formula ##STR1## in which R is an optionally substituted aryl or heterocyclic radical, R.sup.1 is a hydrocarbon radical which is optionally interrupted by 1 oxygen atom in the chain, and/or which is optionally substituted, R.sup.4 is an aliphatic hydrocarbon radical having 7 to 14 carbon atoms, which is optionally interrupted by one oxygen atom and/or which is optionally substituted, R.sup.2 and R.sup.3 each independently is hydrogen, an alkyl radical, an aryl radical or an aralkyl radical, or, for the case where one of the substituents R.sup.2 or R.sup.3 has the above-mentioned meaning, the other is hydroxymethyl, acetoxymethyl or amino, and X is N-R.sup.5, wherein R.sup.5 is hydrogen, an alkyl radical which is optionally interrupted by an oxygen atom, a morpholinoalkyl radical, an aryl radical or an aralkyl radical or X is an oxygen atom, when one of the radicals R.sup.2 or R.sup.3 denotes an amino group, or pharmaceutically acceptable acid addition salts thereof, exhibit hypotensive activity.
式为##STR1##的化合物,其中R是一个可选取代的芳基或杂环基,R.sup.1是一个碳链中可选地被1个氧原子打断的烃基,和/或可选取代的烃基,R.sup.4是一个具有7到14个碳原子的脂肪烃基,该基可选地被一个氧原子打断和/或可选取代,R.sup.2和R.sup.3各自独立地是氢、烷基基、芳基或芳基烷基,或者,如果其中一个取代基R.sup.2或R.sup.3具有上述含义,另一个是羟甲基、乙酰氧甲基或氨基,X是N-R.sup.5,其中R.sup.5是氢、可选地被一个氧原子打断的烷基基、吗啡环烷基、芳基或芳基烷基,或者X是一个氧原子,当R.sup.2或R.sup.3中的一个表示氨基时,或其药学上可接受的酸盐,表现出降压活性。